Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,413.41
(
0.17%
)
US TECH 100
28,446.80
(
0.56%
)
Dow Jones
49,517.34
(
-0.49%
)
Brent Oil
105.31
(
-0.43%
)
Bitcoin
79,417.15
(
-1.33%
)
News Focus
News Focus
Post# of 19615
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Alice-N-Wonderland

Send PM Follow Ignore
Followers 13
Posts 400
Boards Moderated 0
Alias Born 02/15/2010

Alice-N-Wonderland

Re: MT101 post# 18630

Thursday, 07/28/2022 1:36:11 AM

Thursday, July 28, 2022 1:36:11 AM

Post# of 19615
$GOVX

As I reported in a previous article, the company’s CEO, David Dodd, wrote in May that the firm’s “vaccines have been validated and registered for [the] prevention of Monkeypox virus infection.” And, in the same post, Dodd specified that one of the company’s shots may stop humans from contracting monkeypox.

Elaborating in June, the CEO reported that: “We already have published in peer-reviewed journals that our MVA vaccines, in addition [to] protecting animal models against HIV and other infections, also prevents monkeypox,” He vowed that his company would “address the monkeypox virus.”

https://investorplace.com/2022/07/why-is-geovax-govx-stock-up-90-today/

https://investorplace.com/author/larryramerdos/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GOVX News
More GOVX News